Literature DB >> 12463597

Acute myeloid leukemia (FAB-M2) with a masked type of t(8;21) translocation revealed by spectral karyotyping.

Jun-ichi Miyagi1, Naoki Kakazu, Masato Masuda, Takashi Miyagi, Tamiko Toyohama, Tetsuro Nakazato, Takeaki Tomoyose, Tetsuharu Shinjyo, Akitoshi Nagasaki, Naoya Taira, Misao Ohki, Tatsuo Abe, Nobuyuki Takasu.   

Abstract

We report a case of acute myeloid leukemia (AML), M2 subtype according to the French-American-British (FAB) classification, with extramedullary myeloblastoma of the uterus and a masked type of variant translocation of t(8;21)(q22;q22). A 45-year-old Japanese woman presented with metrorrhagia, and AML (M2) with uterine invasion was diagnosed. The patient received an allogeneic peripheral blood stem cell transplantation after remission, and her pelvis was irradiated locally. Cytogenetic study at first showed t(8;17)(q22;p13) by G-banding. Spectral karyotyping (SKY) analysis modified this interpretation to a 3-way translocation involving chromosomes 8,17, and 21 and identified a masked type of variant t(8;21)(q22;q22) translocation. Results of fluorescence in situ hybridization using the AML1/ETO probe, and of detection of the AML1/ETO fusion transcript by reverse transcriptase-polymerase chain reaction were consistent with the karyotyping result. SKY analysis is useful to compensate for the limitations of cytogenetic studies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12463597     DOI: 10.1007/bf02982693

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  29 in total

1.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

2.  Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome.

Authors:  N Kakazu; M Taniwaki; S Horiike; K Nishida; T Tatekawa; M Nagai; T Takahashi; T Akaogi; J Inazawa; M Ohki; T Abe
Journal:  Genes Chromosomes Cancer       Date:  1999-12       Impact factor: 5.006

3.  Translocation (8;12;21)(q22.1;q24.1;q22.1): a new masked type of t(8;21)(q22;q22) in a patient with acute myeloid leukemia.

Authors:  K Saitoh; I Miura; A Ohshima; N Takahashi; M Kume; S Utsumi; Y Kobayashi; K Hashimoto; Y Hatano; T Nimura; M Saito; K Enomoto; M Ohhira; K Shimizu; M Ohki; A B Miura
Journal:  Cancer Genet Cytogenet       Date:  1997-07-15

4.  ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease.

Authors:  P F Erickson; G Dessev; R S Lasher; G Philips; M Robinson; H A Drabkin
Journal:  Blood       Date:  1996-09-01       Impact factor: 22.113

5.  Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.

Authors:  J C Byrd; R B Weiss; D C Arthur; D Lawrence; M R Baer; F Davey; E S Trikha; A J Carroll; R Tantravahi; M Qumsiyeh; S R Patil; J O Moore; R J Mayer; C A Schiffer; C D Bloomfield
Journal:  J Clin Oncol       Date:  1997-02       Impact factor: 44.544

6.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

7.  Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2.

Authors:  E Hilgenfeld; H Padilla-Nash; N McNeil; T Knutsen; C Montagna; J Tchinda; J Horst; W D Ludwig; H Serve; T Büchner; W E Berdel; E Schröck; T Ried
Journal:  Br J Haematol       Date:  2001-05       Impact factor: 6.998

8.  Comparison of spectral karyotyping and conventional cytogenetics in 39 patients with acute myeloid leukemia and myelodysplastic syndrome.

Authors:  B Mohr; M Bornhäuser; C Thiede; U Schäkel; M Schaich; T Illmer; U Pascheberg; G Ehninger
Journal:  Leukemia       Date:  2000-06       Impact factor: 11.528

9.  Mutations in the p53 gene in myelodysplastic syndromes.

Authors:  P Jonveaux; P Fenaux; I Quiquandon; J M Pignon; J L Laï; M H Loucheux-Lefebvre; M Goossens; F Bauters; R Berger
Journal:  Oncogene       Date:  1991-12       Impact factor: 9.867

10.  Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.

Authors:  J L Lai; C Preudhomme; M Zandecki; M Flactif; M Vanrumbeke; P Lepelley; E Wattel; P Fenaux
Journal:  Leukemia       Date:  1995-03       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.